To receive a Sponsorship & Exhibition Prospectus please complete an Expression of Interest form:
Seqirus has public health protection at its core, reflecting the promise of our parent company - CSL Limited - which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many thousands of people around the world. Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine, and produces a range of unique medicines in the national interest including antivenoms and Q fever vaccine. Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products including PALEXIA® IR (tapentadol immediate release), PALEXIA® SR (tapentadol sustained release), VERSATIS® (lidocaine [lignocaine]) and CALDOLOR® (ibuprofen IV).
Medistar is a Brisbane-based independent medical device distributor recognised for supplying innovative technologies to health professionals in Australia and New Zealand. The recently approved gammaCoreTM (nVNS) is the first non-invasive, hand-held medical therapy that can be self-administered by patients for management of cluster headache and migraine. The Nimbus RF multi-tined expandable electrode incorporates a novel design to deliver a consistently larger treatment area, shorter procedures times and improved outcomes. Clarius is the ultimate Handheld Ultrasound System. Wireless and app-based, Clarius delivers fast imaging and sharp detail at the point of care. Cover the scanner and your smartphone completely to reduce the risk of infection.
